According to a market report by Lucintel, the future of the global siRNA conjugate market looks promising with opportunities in the gene therapy and drug delivery markets. The global siRNA conjugate market is expected to reach an estimated $4 billion by 2035 with a CAGR of 13.5% from 2026 to 2035. The major drivers for this market are the increasing demand for gene therapies, the rising focus on targeted drug delivery, and the growing investment in molecular research.
A more
than 150-page report to understand trends, opportunity and forecast in global siRNA
conjugate market to 2035 by type (antibody-siRNA conjugates, GalNAc-siRNA
conjugates, peptide-siRNA conjugates, and others), application (gene therapy,
drug delivery, and others), and region (North America, Europe, Asia Pacific,
and the Rest of the World).
Lucintel
forecasts that, within the type category, antibody-siRNA conjugate is expected
to witness the highest growth over the forecast period.
Within the
application category, gene therapy is expected to witness higher growth.
Download
sample by clicking on siRNA conjugate
market.
In terms
of region, APAC is expected to witness the highest growth over the forecast
period.
WuXi XDC,
Creative Biogene, Bachem, LGC Biosearch Technologies, Sinopep, Organix, CD
Formulation, Hitgen, Alnylam Pharmaceuticals, Amerigo Scientific are the major
suppliers in the siRNA conjugate
market.
This unique research
report will enable you to make confident business decisions in this globally
competitive marketplace. For a detailed table of contents, contact Lucintel at
+1-972-636-5056 or write us at helpdesk@lucintel.com. To get access of more than 1000 reports at fraction of cost
visit Lucintel's Analytics
Dashboard.
About Lucintel
At Lucintel, we offer solutions for
you growth through game changer ideas and robust market &
unmet needs analysis. We are based in
Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20
years. We are quoted in several publications like the Wall Street Journal,
ZACKS, and the Financial Times.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: roy.almaguer@lucintel.com
Tel. +1-972-636-5056
Explore Our Latest Publications
Cocamide Diethanolamine Market